Skip to content

Identification of Genetic Causes of Bicuspid Aortic Valve Disease

Identification of Genetic Causes of Bicuspid Aortic Valve Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01026571
Acronym
BAV Genetics
Enrollment
11000
Registered
2009-12-04
Start date
2009-12-01
Completion date
2030-12-01
Last updated
2026-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bicuspid Aortic Valve

Keywords

Bicuspid aortic valve

Brief summary

BAVgenetics is a partnership between Investigators at Boston University, Brigham and Women's Hospital, and Massachusetts General Hospital dedicated to discovering the genetic causes of bicuspid aortic valve disease and associated aortic disease.

Detailed description

The Investigators at BAVgenetics are dedicated to discovering the mechanisms of bicuspid aortic valve disease and why individual genetics seem to play such an important role in generation of this disease. If you have, or have had, a bicuspid aortic valve, we seek your help in this effort by volunteering to donate DNA to the BAV Registry, so that this disease can be better understood and therapies for it can be developed. The BAV Registry is comprised of patients who have donated DNA collected from saliva (spit) and have provided us with personal health information that tells us about their bicuspid aortic valve. Individuals in the Registry have signed the consent form, filled out the medical history questionnaire and the authorization form, and provided DNA via our saliva sample kits. We will send you the requisite forms so that you receive the most up-to-date information about the study as older forms may be outdated. We also need paper copies of the forms; therefore, we send all the forms via ground mail along with a pre-paid return envelope for your convenience.

Interventions

None listed

Sponsors

Boston University
Lead SponsorOTHER
Massachusetts General Hospital
CollaboratorOTHER
Brigham and Women's Hospital
CollaboratorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Any adult patient ≥ 14 years of age may be recruited regardless of gender, ethnicity or racial group. * Patients with a diagnosis of bicuspid aortic valve will be enrolled. * Patients who have had their bicuspid aortic valve previously replaced will also be enrolled. * Relatives of patients with a diagnosis of bicuspid aortic valve are also welcomed to be enrolled regardless if they have BAV or not, as it is helpful to examine the DNA of first degree relatives.

Exclusion criteria

* Non-English speaking

Design outcomes

Primary

MeasureTime frame
Identification of genetic variants associated with the occurrence of bicuspid aortic valve disease20 years

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSimon C Body, MD MPH

Boston University, Anesthesiology Department

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026